Establishing sheep as an experimental species to validate ultrasound-mediated blood-brain barrier opening for potential therapeutic interventions
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Rationale: Treating diseases of the brain such as Alzheimer's disease (AD) is challenging as the blood-brain barrier (BBB) effectively restricts access of a large number of potentially useful drugs.A potential solution to this problem is presented by therapeutic ultrasound, a novel treatment modality that can achieve transient BBB opening in species including rodents, facilitated by biologically inert microbubbles that are routinely used in a clinical setting for contrast enhancement.However, in translating rodent studies to the human brain, the presence of a thick cancellous skull that both absorbs and distorts ultrasound presents a challenge.A larger animal model that is more similar to humans is therefore required in order to establish a suitable protocol and to test devices.Here we investigated whether sheep provide such a model.Methods: In a stepwise manner, we used a total of 12 sheep to establish a sonication protocol using a spherically focused transducer.This was assisted by ex vivo simulations based on CT scans to establish suitable sonication parameters.BBB opening was assessed by Evans blue staining and a range of histological tests.Results: Here we demonstrate noninvasive microbubble-mediated BBB opening through the intact sheep skull.Our non-recovery protocol allowed for BBB opening at the base of the brain, and in areas relevant for AD, including the cortex and hippocampus.Linear time-shift invariant analysis and finite element analysis simulations were used to optimize the position of the transducer and to predict the acoustic pressure and location of the focus.Conclusion: Our study establishes sheep as a novel animal model for ultrasound-mediated BBB opening and highlights opportunities and challenges in using this model.Moreover, as sheep develop an AD-like pathology with aging, they represent a large animal model that could potentially complement the use of non-human primates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical trial of blood-brain barrier disruption by pulsed ultrasound
Carpentier, A., Canney, M., Vignot, A., Reina, V., Beccaria, K., Horodyckid, C., Karachi, C., Leclercq, D., Lafon, C., Chapelon, J.-Y., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6086 · Cited by 757 · cited 1×
“This circumvents the need to transmit ultrasound through the skull bone but the method also has its limitations [6].”
Hynynen, K., McDannold, N., Sheikov, N. A., Jolesz, F. A., & Vykhodtseva, N. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2004.06.046 · Cited by 679
Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer’s disease mouse model
Leinenga, G., & Götz, J. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa2512 · Cited by 498 · cited 3×
“To visualize BBB opening, we used Evans blue extravasation as done by us previously [19].”
BackgroundMethodSelf-citationJordão, J. F., Thévenot, E., Markham-Coultes, K., Scarcelli, T., Weng, Y.-Q., Xhima, K., O'Reilly, M., Huang, Y., McLaurin, J., Hynynen, K., et al. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.05.008 · Cited by 326 · cited 1×
“Brain uptake of an antibody targeting amyloid plaques was shown to increase in a mouse model for Alzheimer's disease (AD) [20], and obicodilation also proved effective and safe in removing toxic protein aggregates in AD mouse models, either in combination with a therapeutic antibody [21,22], or on its own [19,22-25],…”
BackgroundBurgess, A., Dubey, S., Yeung, S., Hough, O., Eterman, N., Aubert, I., & Hynynen, K. (2014) · Radiology · doi:10.1148/radiol.14140245 · Cited by 286 · cited 1×
“Brain uptake of an antibody targeting amyloid plaques was shown to increase in a mouse model for Alzheimer's disease (AD) [20], and obicodilation also proved effective and safe in removing toxic protein aggregates in AD mouse models, either in combination with a therapeutic antibody [21,22], or on its own [19,22-25],…”
BackgroundNisbet, R. M., Van der Jeugd, A., Leinenga, G., Evans, H. T., Janowicz, P. W., & Götz, J. (2017) · Brain · doi:10.1093/brain/awx052 · Cited by 187
Self-citationChoi, J. J., Pernot, M., Brown, T. R., Small, S. A., & Konofagou, E. E. (2007) · Physics in Medicine and Biology · doi:10.1088/0031-9155/52/18/004 · Cited by 141 · cited 1×
“Brain uptake has been demonstrated for MRI contrast agents [15,16], fluorescently labeled dextrans [17] and the dye Evans blue [18,19], which are normally excluded from the brain.”
BackgroundFan, C.-H., Liu, H.-L., Ting, C.-Y., Lee, Y.-H., Huang, C.-Y., Ma, Y.-J., Wei, K.-C., Yen, T.-C., & Yeh, C.-K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096327 · Cited by 84
Hatch, R. J., Leinenga, G., & Götz, J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0164278 · Cited by 34
Self-citation
Cited by
The blood-brain barrier: Physiology and strategies for drug delivery
Pandit, R., Chen, L., & Götz, J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.11.009 · Cited by 651
Self-citationApplications of focused ultrasound in the brain: from thermoablation to drug delivery
Meng, Y., Hynynen, K., & Lipsman, N. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-020-00418-z · Cited by 505
Leinenga, G., Koh, W. K., & Götz, J. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00809-4 · Cited by 97
Self-citationElbaz, M., Ad-El, N., Chulanova, Y., Brier, D., Goldsmith, M., Bismuth, M., Brosque, A., Sher, D., Gutkin, A., Bar-On, D., et al. (2025) · doi:10.1101/2025.01.23.634427 · Cited by 43
Rouhi, N., Chakeri, Z., Ghorbani Nejad, B., Rahimzadegan, M., Rafi Khezri, M., Kamali, H., & Nosrati, R. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37533 · Cited by 20
“Although the safety and the noninvasive FUS/MBs-mediated BBB opening in the hippocampus and cortex was indicated in sheep as AD model [156], the safety of FUS/MBs-induced AD drug delivery was recently claimed in the clinical trial studies.”
BackgroundPatwardhan, A., Wilkinson, T., Meng, Y., Alhashyan, I., Black, S. E., Lipsman, N., & Masellis, M. (2024) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2024.85 · Cited by 15
Nestor, P. J., Pelekanos, M., Leinenga, G., Song, J., Lee, W., Richter-Stretton, G., McElligott, C., Fazlollahi, A., Mattingley, J. B., Harris, A., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf445 · Cited by 3
Self-citationMultidimensional Safety Assessment of a Low-Intensity Scanning Ultrasound (SUS) Protocol in Sheep
Song, J., Pelekanos, M., Richter-Stretton, G., Leinenga, G., Chicoteau, A., Lee, W., Odabaee, M., Nestor, P. J., Saifzadeh, S., Simon, C., et al. (2026) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2026.06.011
Self-citation
Metadata
- Authors
- Pelekanos, M., Leinenga, G., Odabaee, M., Odabaee, M., Saifzadeh, S., Steck, R., & Götz, J.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2018
- Volume
- 8
- Issue
- 9
- Pages
- 2583-2602
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W2802079221
- Cited by
- 59
- References
- 9
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.